Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS Health Corp

Where You Can Put Your Money in a Bear Market

After more than a decade of astronomical growth, the stock market has steadily declined since early 2022. On June 13, the S&P 500 plunged into a bear market, closing by slightly less than 4%, representing a 21% drop from Jan. 3 high. Technology and Blue-chip stocks got hit as severely,…

Benzinga

Effect Of Roe Vs. Wade Ruling - Pharmacies Ration Contraceptive Pills

Major pharmacies like CVS Health Corp (NYSE:CVS), Walmart Inc (NYSE:WMT), and Rite Aid Corporation (NYSE:RAD) have put a limit on purchases or deliveries of Plan B and other emergency contraceptive pills, writes Wall Street Journal. The move comes as demand for contraceptive pills spiked following the Supreme Court ruling overturning a constitutional right to abortion. These were in…

Benzinga

CVS Stops Filling Controlled Substance Prescriptions From Two Telehealth Firms: Report

CVS Health Corp. (NYSE: CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

CVS Health To Stop Filling Controlled Substances Prescriptions For Cerebral, Done Health

CVS Health Corp (NYSE: CVS) will stop

Benzinga

Ohio Lawyer Says Pharmacy Distributors To Pay $878M For Opioid Epidemic

A lawyer for two Ohio counties said that CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance Inc (NASDAQ:WBA), and Walmart Inc (NYSE:WMT) should fund an $878 million plan addressing the opioid crisis, writes Reuters. In November, a federal jury decided that the companies created a public nuisance by flooding Ohio's Lake and Trumbull counties with addictive prescription pain…

Benzinga

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

Benzinga

Walgreens Announces $683M Opioid Settlement With Florida

Walgreens Boots Alliance Inc (NASDAQ:WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state. The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal fees. The settlement ends a trial that began…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why CVS Health Shares Are Rising

CVS Health Corp (NYSE: CVS) shares are trading higher by 3.97% at $99.79 after the company reported better-than-expected first-quarter EPS and sales results. The company also raised its FY22 EPS guidance.

Benzinga

CVS Health Q1 Earnings Beat Street Expectations, Raises FY22 Adjusted EPS Forecast

CVS Health Corp's (NYSE:CVS) Q1 sales increased 11.2% Y/Y to $76.83 billion, beating the consensus of $75.39 billion. Adjusted operating income increased 6.6% to $4.48 billion primarily due to increased prescription and front store volume, including the sale of COVID-19 OTC test kits and the impact of COVID-19 vaccinations in the Retail/LTC…

Benzinga

How Markets Are Playing CVS Health, T-Mobile US

On CNBC's "Options Action," Carter Worth said CVS Health Corp (NYSE: CVS) “acts poorly going into earnings.” He added, “If you’re long, we’ll take measures.

Benzinga

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters

Alabama reached $276 million in settlements with Johnson & Johnson (NYSE:JNJ), McKesson Corporation (NYSE:MCK), and Endo International Plc (NASDAQ:ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will pay $141 million. JNJ and Endo will pay $70.3 million and $25 million, respectively, Alabama Attorney General Steve Marshall said in a statement. The three…

Benzinga

CNBC's Final Trades: CVS Health, AbbVie And This Travel Stock

On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners recommended to sell CVS Health Corp (NYSE: CVS).

Benzinga

CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report

Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic.

Benzinga

Hims & Hers Health Expands Skincare Offerings

Hims & Hers Health Inc (NYSE:HIMS) has expanded its skincare collections, including a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil. "We've listened to Hers customers' personal skincare concerns regarding their top skincare recommendations in order to provide the most personalized skincare experience possible, whether one product is used or six,"…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Going On With CVS Health Shares Today?

CVS Health Corp (NYSE: CVS) is trading lower Wednesday after the company announced its fourth-quarter financial results and reaffirmed guidance.

Benzinga

How CVS Health's Stock Looks Heading Into Q4 Earnings Print

CVS Health Corp (NYSE: CVS) popped up more than 1% higher on Tuesday, which put the stock into blue skies. The stock has run over 11% higher since reaching a low of $99.69 on Jan. 24.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.